We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
- Authors
Tang, Tiffany; Chen, Zhengming; Praditsuktavorn, Pannee; Khoo, Lay Poh; Ruan, Jia; Lim, Soon Thye; Tan, Daryl; Phipps, Colin; Lee, Yuh Shan; Goh, Yeow Tee; Hwang, William; Tao, Miriam; Quek, Richard; Farid, Mohamad; Furman, Richard R.; Leonard, John P.; Martin, Peter
- Abstract
<bold>Introduction: </bold>The role of surveillance imaging (SI) in patients with peripheral T-cell lymphoma (PTCL) in first complete remission (CR1) is unclear.<bold>Materials and Methods: </bold>Patients with PTCL were identified through prospectively maintained T-cell lymphoma databases from the National Cancer Centre Singapore/Singapore General Hospital and Weill-Cornell Medical College after institutional review board approval. Patients with leukemia or indolent, composite, and cutaneous lymphomas were excluded. The patients' medical records were retrospectively reviewed to determine the frequency and type of SI used. Of those with relapse, the method of relapse detection and data on symptoms, signs, and elevated lactate dehydrogenase LDH were extracted.<bold>Results: </bold>A total of 338 patients were included in the present study. In the first year after achieving CR1, patients had an average of 1.2 and a median of 1 SI performed (range, 0-4). In the second year after achieving CR1, they had an average of 0.78 and a median of 1 SI performed (range, 0-4). Of the 135 patients who achieved CR1, 61 (45%) developed a relapse. Relapses were detected before SI in 48 (84%), and 9 patients had relapses detected during routine SI. Of the 9 patients whose relapses were detected during planned SI, only 3 did not have any symptoms or signs suggestive of relapsed disease. Of these 3 patients, 2 had angioimmunoblastic T-cell lymphoma and 1 had natural killer/T-cell lymphoma.<bold>Conclusion: </bold>Most PTCL relapses were detected before planned SI, and most patients had symptoms with relapse. Only 3 patients (5.2%) were completely asymptomatic at relapse, suggesting a limited utility of routine imaging for detecting PTCL relapses.
- Subjects
COMBINED modality therapy; DIAGNOSTIC imaging; EVALUATION of medical care; PROGNOSIS; TUMOR classification; DISEASE relapse; TREATMENT effectiveness; DISEASE remission; RETROSPECTIVE studies; TUMOR grading; T-cell lymphoma; DIAGNOSIS; THERAPEUTICS
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2016, Vol 16, Issue 3, p117
- ISSN
2152-2650
- Publication type
journal article
- DOI
10.1016/j.clml.2015.12.006